Assignee
DISPERSOL TECHNOLOGIES LLC
US·3 granted patents·8 pending applications·13 citations·filing 2014–2020
Top patents by PatentIndex Score
11 records- 0186US10258608B2Formulations of deferasirox and methods of making the sameDISPERSOL TECHNOLOGIES LLC·Filed 2017·Granted Apr 16, 2019·3 cites·7 claims
- 0283US10265301B2Formulations of deferasirox and methods of making the sameDISPERSOL TECHNOLOGIES LLC·Filed 2016·Granted Apr 23, 2019·5 cites·24 claims
- 0379US9821283B1Direct probe sensed temperature method for speed change for heat sensitive portions of a thermokinetically melt blended batchDISPERSOL TECHNOLOGIES LLC·Filed 2014·Granted Nov 21, 2017·5 cites·22 claims
- 0455US2019142756A1Drug formulationsDISPERSOL TECHNOLOGIES LLC·Filed 2018·Application pending·0 cites
- 0551US2021128536A1Weakly basic drug and ionic polymer pharmaceutical formulations and methods of formation and administration thereofDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 0648US2019091339A1Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereofDISPERSOL TECHNOLOGIES LLC·Filed 2018·Application pending·0 cites
- 0747US2021087191A1SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-a]ISOQUINOLIN-2-OL COMPOUNDS, THEIR SYNTHESIS, AND USE THEREOFDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 0846US2022401579A1Inclusion complexes of pharmaceuticals and cyclic oligomersDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 0944US2022362264A1Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereofDISPERSOL TECHNOLOGIES LLC·Filed 2020·Application pending·0 cites
- 1040US2020009060A1Improved drug formulationsDISPERSOL TECHNOLOGIES LLC·Filed 2017·Application pending·0 cites
- 1137US2017333404A1Improved formulations of vemurafenib and methods of making the sameDISPERSOL TECHNOLOGIES LLC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →